Skip to the page

Data / Form D filings / PEPTINOVO BIOPHARMA INC.

PEPTINOVO BIOPHARMA INC.: Form D filings

PEPTINOVO BIOPHARMA INC., a biotechnology company in Ann Arbor, MI, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on December 16, 2024, reports $1.3 million sold of a $10 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
600 S. WAGNER ROAD, Ann Arbor, MI, 48103
Phone
(734) 330-0265
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1868564

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 16, 2024Amendment$10,000,000$1,297,885$8,702,11512Sep 10, 2024sec.gov
Sep 24, 2024New notice$10,000,000$1,318,700$8,681,30012Sep 10, 2024sec.gov
Jun 21, 2021New noticeIndefinite$955,00012Jun 7, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
DAVID ROMENESCODirector
FRED BROWNDirector
REYNOLD HOMANExecutive Officer, Director
BILL ELLIOTTExecutive Officer
STEVE TOKAZExecutive Officer, Director

Other biotechnology companies in Michigan that filed recently

Every Form D from the week of Dec 16, 2024 · All recent filings in Michigan · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what PEPTINOVO BIOPHARMA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.